NCT00389740View on ClinicalTrials.gov

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 2, 2001

Primary Completion Date

January 16, 2003

Study Completion Date

January 16, 2003

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

MK0217, /Duration of Treatment : 12 Months

DRUG

Comparator : raloxifene hydrochloride /Duration of Treatment : 12 Months

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00389740 - A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) | Biotech Hunter | Biotech Hunter